Lipocine
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $114 | $622 | $93 | $3,491 |
Gross Profit | 114 | -1,513 | 93 | 3,491 |
EBITDA | -3,344 | -2,388 | -2,074 | 1,561 |
EBIT | -3,361 | -2,404 | -2,090 | 1,545 |
Net Income | -3,186 | -2,205 | -1,864 | 1,782 |
Net Change In Cash | 114 | 622 | 93 | 3,491 |
Free Cash Flow | -2,985 | -1,886 | -1,969 | 1,691 |
Cash | 3,901 | 6,043 | 3,354 | 6,205 |
Basic Shares | 5,413 | 5,351 | 5,348 | 5,422 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $11,198 | $-2,850 | $500 | $16,140 |
Gross Profit | 11,198 | -13,026 | -8,056 | 8,475 |
EBITDA | -1,113 | -17,902 | -10,721 | -430 |
EBIT | -1,155 | -17,930 | -10,730 | -430 |
Net Income | 8 | -16,352 | -10,758 | -634 |
Net Change In Cash | 11,198 | -2,850 | 500 | 16,140 |
Cost of Revenue | -21,266 | |||
Free Cash Flow | -1,311 | -11,879 | -12,102 | -4,418 |
Cash | 6,205 | 4,771 | 3,148 | 2,950 |
Basic Shares | 5,422 | 5,269 | 5,256 | 5,154 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.59 |
2025-06-30 | -$0.41 |
2025-03-31 | -$0.35 |
2024-12-31 | $0.33 |
